ELOXX PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$2.67 million for the 12-month period ending 2025-12-31, per its S-1 filed 2026-09-11.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$22.99M.
- ELOXX PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$47.85M.
- ELOXX PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$18.58M.
- ELOXX PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was -$22.24M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$2.67M S-1 · filed 2026-09-11 | |
| 2024-12-31 | $637.00K S-1 · filed 2026-09-11 | |
| 2023-12-31 | -$7.70M S-1 · filed 2026-09-11 | |
| 2022-12-31 | -$22.99M 10-K · filed 2023-03-31 | |
| 2021-12-31 | -$47.85M 10-K · filed 2023-03-31 | |
| 2020-12-31 | -$18.58M 10-K · filed 2022-03-30 | |
| 2019-12-31 | -$22.24M 10-K · filed 2022-03-30 | |
| 2018-12-31 | -$24.44M 10-K · filed 2021-03-12 | -$22.62M 10-K · filed 2019-03-14 |
| 2017-12-31 | -$21.00K 10-K · filed 2020-03-06 | -$21.14M 10-K · filed 2018-03-16 |
| 2016-12-31 | -$9.88M 10-K · filed 2019-03-14 | |
| 2015-12-31 | -$6.42M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |